Yonsei Med J. 1991 Jun;32(2):126-130. English.
Published online Feb 20, 2002.
https://doi.org/10.3349/ymj.1991.32.2.126
Published online Feb 20, 2002.
https://doi.org/10.3349/ymj.1991.32.2.126
Copyright © 1991 The Yonsei University College of Medicine
Original Article
Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer
Hyun Cheol Chung,
Dong Lip Kim,
Eun Hee Koh,
Joo Hang Kim,
Jae Kyung Roh,
Jin Sik Min,
Kyung Sik Lee,
Woo Ick Yang,
Byung Soo Kim
and Kyi Beom Lee
Abstract
Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.
Keywords
Male breast cancer; EGFR; ER
Cited by
MeSH Terms
Permalink information copied to clipboard